CenterHigh
KABC / ABC7 Los AngelesNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
← Today's headlines
15 sources checked · 2 source groups included · 26m ago
Still Watching
FDA approves Moderna's m RNA seasonal flu vaccine
ABC7 New York and American Greatness describe the same event in different terms.
0 Left14 Center1 Right
STILL WATCHING
As of August 6, 2026 at 10:58 AM, this is how Optics News reads the wording differences in this story.
What happened The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
The headline split The center frames it as "FDA approves Moderna's m RNA seasonal flu vaccine". The right frames it as "Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine".
Match confidence Medium confidence. 15 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
15 sources across 2 bias buckets agree on the event.
Framing confidenceMild
43/99 — small wording differences, not a major framing split.
WHAT EACH SIDE EMPHASIZED
Left / center-leftNo matching source in this bucket yet.
Optics keeps watching for pickup.
CenterFDA approves Moderna's m RNA seasonal flu vaccine
KABC / ABC7 Los Angeles · Center · News report
Right / center-rightMorning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
American Greatness · Right · News report
SEE THE HEADLINES
Open source
CenterHigh
KCRA3 Sacramento (Hearst)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
WISN12 Milwaukee (Hearst)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
WLWT Cincinnati (Hearst)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
WYFF4 (Hearst, Greenville)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
WMTW8 (Hearst, Portland ME)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Show all 15 sources
CenterHigh
KMBC9 (Hearst, Kansas City)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
WGAL Susquehanna / KOAT7 (Hearst, Albuquerque)News report · Aug 6, 10:58 AM
FDA approves first m RNA-based flu vaccine
The FDA approved the United States’ first m RNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
CenterHigh
The Hill - PolicyNews report · Aug 6, 10:39 AM
FDA approves first m RNA flu vaccine
The Food and Drug Administration (FDA) late Wednesday approved the nation's first m RNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two separate age gro...
CenterHigh
WLS / ABC7 ChicagoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KGO / ABC7 San FranciscoNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
WPVI / 6abc PhiladelphiaNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterHigh
KTRK / ABC13 HoustonNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
CenterMostly Factual
ABC7 New YorkNews report · Aug 6, 9:33 AM
FDA approves Moderna's m RNA seasonal flu vaccine
The vaccine, m FLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
RightMixed
American GreatnessNews report · Aug 6, 9:02 AM
Morning Greatness: FDA Approves Moderna’s m RNA Seasonal Flu Vaccine
Good Thursday morning. Here is what’s on President Trump’s agenda today: 8:00 AM THE PRESIDENT participates in Executive Time 10:00 AM THE PRESIDENT participates in […] Source
Details43/99 Wording Gap · Medium confidence · 15 sources
43/99 Wording GapMedium confidence15 sources · 2 bias bucketsLive match · 15 sources · 2 buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Aug 6, 9:02 AM: American Greatness joined the source map.
Aug 6, 9:33 AM: KABC / ABC7 Los Angeles joined the source map.
Aug 6, 9:33 AM: WLS / ABC7 Chicago joined the source map.
Aug 6, 9:33 AM: KGO / ABC7 San Francisco joined the source map.
Now: Wording Gap is 43/99 and story health is live match · 15 sources · 2 buckets · comparable news format.